Stratec SE

SBS

DE000STRA555

Advanced Medical Equipment & Technology

Market Closed - Xetra Other stock markets 11:35:01 2024-05-03 am EDT			5-day change	1st Jan Change
42.5 ^EUR	-0.82%		+2.04%	-6.70%

Apr. 29	STRATEC BIOMEDICAL SYSTEMS AG : Deutsche Bank reiterates its Neutral rating	ZD
Apr. 26	STRATEC BIOMEDICAL SYSTEMS AG : Berenberg reiterates its Neutral rating	ZD

STRATEC BIOMEDICAL SYSTEMS AG : Berenberg reiterates its Neutral rating

April 25, 2024 at 07:39 am EDT

In a research note published by Odysseas Manesiotis, Berenberg gives a Neutral rating to the stock. The target price is decreased from EUR 43 to EUR 41.

Latest news about Stratec SE

STRATEC BIOMEDICAL SYSTEMS AG : Deutsche Bank reiterates its Neutral rating	Apr. 29	ZD
STRATEC BIOMEDICAL SYSTEMS AG : Berenberg reiterates its Neutral rating	Apr. 26	ZD
STRATEC BIOMEDICAL SYSTEMS AG : Warburg Research remains Neutral	Apr. 26	ZD
Stratec sees revival in second quarter - share price jumps	Apr. 26	DP
Stratec SE Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Weak start to the year for Stratec - recovery expected in the second quarter	Apr. 26	DP
STRATEC BIOMEDICAL SYSTEMS AG : Berenberg reiterates its Neutral rating	Apr. 25	ZD
STRATEC BIOMEDICAL SYSTEMS AG : Warburg Research remains Neutral	Apr. 10	ZD
STRATEC BIOMEDICAL SYSTEMS AG : DZ Bank reiterates its Neutral rating	Apr. 08	ZD
STRATEC BIOMEDICAL SYSTEMS AG : Deutsche Bank sticks Neutral	Apr. 04	ZD
STRATEC BIOMEDICAL SYSTEMS AG : Hauck & Aufhauser remains Neutral	Apr. 03	ZD
Stratec remains under pressure - LBBW: Predictability limited	Apr. 02	DP
STRATEC BIOMEDICAL SYSTEMS AG : Deutsche Bank remains Neutral	Apr. 02	ZD
Transcript : Stratec SE, 2023 Earnings Call, Mar 28, 2024	Mar. 28
Stratec SE Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
STRATEC BIOMEDICAL SYSTEMS AG : Gets a Neutral rating from Warburg Research	Mar. 28	ZD
Berenberg rates Stratec at 'Hold' - Target 43 euros	Mar. 28	DP
STRATEC BIOMEDICAL SYSTEMS AG : Berenberg sticks Neutral	Mar. 28	ZD
Stratec development disappoints - Significant minus also for 2024	Mar. 28	DP
Stratec continues to struggle with customer destocking - share price falls	Mar. 28	DP
Stratec continues to struggle with inventory reduction at customers - hopes for improvement	Mar. 28	DP
STRATEC BIOMEDICAL SYSTEMS AG : Deutsche Bank gives a Neutral rating	Mar. 22	ZD
Diagnostics specialist Stratec significantly reduces dividend	Mar. 21	DP
Stratec SE Proposes Dividend for Financial Year 2023	Mar. 21	CI
Hauck Aufhäuser IB lowers Stratec to 'Hold' - target 40 euros	Jan. 22	DP

Stratec SE is a Germany-based company engaged in the development and manufacture of fully automated systems based on its own patented technologies for its partners in the fields of in-vitro diagnostics and life sciences in Germany and internationally. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-13 - UBS Pan European Small and Mid Cap Conference

More about the company

Income Statement Evolution

More financial data

Ratings for Stratec SE

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

42.5 EUR

Average target price

43.83 EUR

Spread / Average Target

+3.14%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
STRATEC SE	-6.70%	557M
THERMO FISHER SCIENTIFIC	+7.84%	218B
DANAHER CORPORATION	+7.35%	184B
INTUITIVE SURGICAL, INC.	+13.04%	135B
BOSTON SCIENTIFIC CORPORATION	+26.03%	107B
SIEMENS HEALTHINEERS AG	-1.33%	62.38B
EDWARDS LIFESCIENCES CORPORATION	+11.80%	51.37B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.81%	50.9B
AGILENT TECHNOLOGIES, INC.	+0.30%	40.87B
GE HEALTHCARE TECHNOLOGIES INC.	+2.78%	36.28B

Other Advanced Medical Equipment & Technology

Stratec SE

Equities

SBS

DE000STRA555

Advanced Medical Equipment & Technology

STRATEC BIOMEDICAL SYSTEMS AG : Berenberg reiterates its Neutral rating

Latest news about Stratec SE

Chart Stratec SE

Company Profile

Income Statement Evolution

Ratings for Stratec SE

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Other Advanced Medical Equipment & Technology